Violaine Bordeneuve-Plante - Publications

Guidelines for the management of hereditary ATTR amyloidosis 2026.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: July 09, 2026

A case of acute myelopathy in ATTR-Val30Met amyloidosis with leptomeningeal involvement: pathophysiological insights and upcoming therapeutic challenges.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: July 20, 2025

Complete remission after patisiran treatment in a patient with nephrotic syndrome secondary to hereditary transthyretin amyloidosis (ATTR).

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: March 06, 2025

Kidney Outcomes in Patients With Hereditary Transthyretin Amyloid Nephropathy Treated With Transthyretin Stabilizers And Gene-Silencer Therapies.

Journal: Kidney international reports

Published: December 05, 2024

Vutrisiran: a new drug in the treatment landscape of hereditary transthyretin amyloid polyneuropathy.

Journal: Expert opinion on drug discovery

Published: January 28, 2024

Rate and characteristics of inflammatory neuropathies associated with brentuximab vedotin therapy.

Journal: European journal of neurology

Published: November 15, 2023

Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: July 17, 2023

Phenotype and prognostic factors in geriatric and non-geriatric patients with transthyretin cardiomyopathy.

Journal: ESC heart failure

Published: June 21, 2023

Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS).

Journal: PloS one

Published: May 26, 2023

Disease risk estimates in V30M variant transthyretin amyloidosis (A-ATTRv) from Mallorca.

Journal: Orphanet journal of rare diseases

Published: May 12, 2023

A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS).

Journal: Orphanet journal of rare diseases

Published: May 11, 2023

A multicentric study of the disease risks and first manifestations in hereditary transthyretin amyloidosis (ATTRv): insights for an earlier diagnosis.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: March 30, 2023